Australia is stepping up its regional leadership in the elimination of cervical cancer, with the announcement of a $12.5 million Australian Government grant to a consortium of leading Australian and international non-government health organisations.
The Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC) is the largest-ever initiative of its kind, leveraging Australian, international and in-country partner expertise to promote the World Health Organisation’s strategy for the elimination of cervical cancer.
The EPICC consortium is comprised of the Kirby Institute at UNSW, The Daffodil Centre (a joint venture between the University of Sydney and Cancer Council NSW), Australian Centre for the Prevention of Cervical Cancer, Family Planning Australia, National Centre for Immunisation Research and Surveillance Australia, and global health agency Unitaid.
EPICC program promotes elimination of cervical cancer
The Kirby Institute will lead in-country implementation and program management support across the new network. The initiative builds upon the success of the Eliminating Cervical Cancer in the Western Pacific (ECCWP) program, which has supported the introduction of sustainable elimination policy and practice in Vanuatu and the Western Highlands region of Papua New Guinea.
“This funding is a welcome boost to supporting cervical cancer elimination in our region,” said Professor Andrew Vallely, Head of Global Reproductive Health at the Kirby Institute.
“Through ECCWP, we have been able to offer vaccination, testing and treatment to thousands of women across Vanuatu and Papua New Guinea, which has saved lives. This new funding enables us to continue supporting our in-country partners in scaling up these efforts, facilitating more equitable access to these lifesaving interventions.”